Rippe, Bengt, and Aubrey Taylor. NEM and filipin increase albumin transport in lung microvessels. Am J Physiol Heart Circ Physiol 280: H34-H41, 2001.-This study was undertaken to evaluate the role of transcytosis as a bulk transfer mechanism for the passage of albumin from blood to tissue. Isolated rat lungs were continuously weighed and perfused with an albumin-serum buffer solution under strictly controlled hemodynamic conditions, which allowed measurements of microvascular pressure and of the capillary filtration coefficient (L p S). With the use of a tissue uptake technique, it was possible to determine lung albumin clearance under isogravimetric conditions (Cl iso ), or at elevated filtration rates, to obtain an "apparent albumin reflection coefficient" ( alb ). Experiments were performed during control and after reducing lung temperature from 35°to 22°C and after infusions of the transcytosis inhibitors N-ethylmaleimide (NEM) or filipin. Cooling moderately increased vascular resistance and reduced L p S and Cl iso largely in proportion to the induced increases in viscosity. At 35°C, NEM (0.13 mM) caused a marked increase in L p 5 and in Cl 150 and also caused a reduction in alb. Furthermore, Cl iso increased for the highest dose of filipin tested (1.8 g/ml). The demonstrated relative cooling insensitivity of the transfer of albumin across the endothelium in rat lungs does not support the contention of transcytosis of proteins across the endothelium. Furthermore, neither NEM nor filipin inhibited lung microvascular albumin transport, but actually increased lung endothelial permeability. capillary permeability; macromolecules; transcytosis; albumin clearance THE IMPORTANCE OF TRANSCYTOSIS as a bulk transporter for macromolecules in the microvascular barrier has been vigorously debated over the past four decades. Ever since the discovery of plasmalemmal vesicles (19) , morphologists have proposed that transcytosis is a major mode of protein transport across vascular endothelia (19) . However, many studies (26) (27) (28) (29) (30) 46 ) have shown that transvascular large solute transport has characteristics that do not comply with "active" transcytosis. From a physiological perspective, transcapillary bulk transport of macromolecules appears to occur through aqueous channels, i.e., through pores or other size-selective structures (slits with a matrix of fibers) in the blood-tissue barrier. Such conclusions are mainly on the basis of a low cooling sensitivity of transvascular protein (albumin) transport (30, 33) and the marked coupling of protein transfer to transcapillary fluid filtration (29, 40) . There have also been studies (2, 3, 7) that used ultrathin (ϳ140 Å) serial sectioning electron microscopy (EM) of endothelial cells from various capillaries that show very few free plasmalemmal vesicles. Virtually all of the free vesicles observed by use of routine EM appear to be stagnant parts of racemous invaginations from the cell surface. This has been demonstrated by both conventional chemical fixation as well as after "ultrarapid" fixation by using slam-freezing (8) .
During the past decade, novel approaches have been applied to discriminate active "vesicular transport" from passive "porous transport." N-ethylmaleimide (NEM) is an alkylating agent that appears to inhibit vesicular transport by interacting with the docking and fusion of vesicles with their target membranes (32, 34) . Filipin is a cholesterol-binding agent that is assumed to inhibit transcytosis by binding to the caveolas and removing cholesterol from the plasmalemma, thereby causing disassembly of the vesicles (36) . Recently, NEM has been claimed to inhibit albumin and small protein transfer in the murine heart (24, 25) as well as albumin transport across the rat lung microvasculature (34) . Furthermore, the transport of radiolabeled albumin across the microvasculature of rat lungs appeared to be partly inhibitable by filipin (36) . These studies were, however, performed in perfusion experiments in situ without continuous monitoring of preand postcapillary resistances, capillary filtration coefficients (L p S), tissue weight, and without previous heparinization of the animals. Furthermore, the degree of vascular wash out achieved, whether complete or not, cannot be determined from these studies.
On the basis of this background, we decided to assess microvascular albumin transport at lowered temperature and after either NEM or filipin under well-controlled hemodynamic conditions in an isolated perfused rat lung. In this experimental model, vascular pressures and pre-and postcapillary resistances could be controlled and measured, respectively, whereas capillary hydraulic conductance could also be assessed. Transvascular tracer albumin transport was measured with the use of an isogravimetric albumin clearance [Cl iso or "apparent permeability suface (PS) area product"], when net transcapillary fluid filtration flux (J v ) was zero. Also, an apparent reflection coefficient for albumin ( alb ) was measured at elevated J v values, by using a dual tracer albumin tissue uptake technique. With the use of these measurements there was no evidence that the "transcytosis inhibitors" employed reduced Cl iso or increased alb . On the contrary, whereas cooling from body temperature to room temperature slightly reduced the Cl iso (largely in proportion to the concomitant increases in perfusate viscosity), both NEM and filipin produced increases in Cl iso and reductions of alb , which is compatible with an increased permeability of the lung endothelial barrier.
METHODS

Isolated Perfused Rat Lung
The isolated rat lung preparation has been previously described (21, 23) . Briefly, male CD rats (Charles River) weighing between 280 and 400 g (345 Ϯ 39 g, means Ϯ SD) were anesthetized with an injection of pentobarbital sodium (65 mg/kg ip). The trachea was cannulated to allow ventilation with a rodent ventilator (model 683; Harvard Apparatus, S. Natick, MA) at 40 breaths/min, a tidal volume of 2.5 ml, and a positive end-expiratory pressure of 3 cmH 2 O. This tidal volume resulted in a mean airway pressure of 4-5 cmH 2 O. The inspired gas was initially room air, which was switched to a 21% O 2 -5% CO 2 -74% N 2 gas mixture when the lung was isolated and perfused. We performed a median sternotomy and injected 300 units of heparin sodium into the right ventricle and allowed it to circulate for at least 3 min. The pulmonary artery (PA) and the left atrium (LA) were then cannulated, and the arterial cannula was attached to a perfusate-filled reservoir and suspended above the animal for the purpose of initiating a low-flow initial washout of the lungs when they were still in situ. The heart, lungs, and mediastinal structures were then carefully excised, and the heart-lung preparation was removed en bloc and suspended in a humid chamber via the tracheal cannula from a straingauge force transducer (model FT03C; Grass Instruments, Quincy, MA) to monitor weight changes. The PA and LA cannulas were then connected to a (heated) perfusion system containing a large (2-3 ml) arterial bubble trap, and the lungs were perfused by using a peristaltic pump (Minipuls 2; Gilson Medical Electronics, Middleton, WI) at ϳ10 ml/g of predicted (initial) lung weight. Perfusate was a physiological salt solution (PSS) containing 5% bovine serum albumin (BSA) (Fraction IV, 66,000 mol wt; Sigma Chemical, St. Louis, MO) and 10 vol% horse serum (HS) (H1270, Sigma Chemical) contained in a heated (38°C) reservoir (ϳ70 ml). HS was added to the perfusate to prevent undue increases in albumin clearance that may occur when serum (orosomucoid) is lacking in the perfusate, the so-called "serum effect" (11, 12) . In five lungs perfused without HS in the perfusate, albumin clearance thus increased about threefold, i.e., from 0.230 Ϯ 0.019 to 0.637 Ϯ 0. 19 Pulmonary arterial (P A ), pulmonary venous (P V ), and airway pressures (P airw ) were measured with the use of pressure transducers (Cobe, Lakewood, CO), and the lung weight was continuously recorded by using the force displacement transducer. P A , P V , P airw , and tissue weight were continuously monitored on a polygraph recorder (model 7B, Grass Instruments, Quincy, MA). Dual perfusion systems, connected to each other via a stopcock just before the PA cannula (and before P A line) and just after the LA cannula (and after the P V line), and having a bypass circuit, allowed rapid shifts between perfusate I and perfusate II, leaving P A , P V , and tissue weight undisturbed. The second perfusion line allowed the nonperfusing solution, usually perfusate II, to bypass the lung preparation while recirculating. Lungs were always perfused in zone III conditions, unless otherwise specified.
Measurements of Pulmonary Capillary Pressure
The pulmonary microvascular pressure (P C ) was estimated by using the double-occlusion technique (38) . Arterial inflow and venous outflow lines were simultaneously occluded, and the pressure at which P A and P V equilibrated was recorded. The equilibration pressure has been shown to be identical with isogravimetric measures of P C .
Measurements of L p S
After an isogravimetric state had been attained (5-10 min), P A and P V were rapidly elevated by 6-8 cmH 2 O for ϳ10 min by increasing the height of the venous outflow cannula and simultaneously increasing blood flow. The ensuing lung weight increase usually shows a characteristic rapid weight gain phase (vascular filling) followed by a slower rate of weight gain (transcapillary filtration). The slow weight gain slope will characteristically decline over time with a halftime (t 1/2 ) of ϳ5 min. We have chosen to use the weight gain rate for the last 2 min of the first 10 min as the slope for our L p S measurements as shown in Eq. 1
where ⌬P c represents the imposed increment of microvascular pressure during the measurement of L p S. It should be noted that L p S measured in this way is one-fourth as high as values obtained from back extrapolation of the slow weight gain curve to zero time (⌬W tϭ0 ) (23), but fourfold higher than values obtained by using ⌬W tϭ20 , i.e., from the slope at 20 min of the weight gain curve (21) . All L p S values (L p S was calculated in units of ml ⅐ min Ϫ1 ⅐ 100 g PLW Ϫ1 , assuming a specific gravity of 1.0 for the filtered fluid.) were normalized to 100 g of predicted lung weight (PLW), which was on the basis of body weight in grams according to (21) 
Vascular Resistances
Perfusate flow (Q) for each experiment was calculated from the PLW and set at 10 ml ⅐ min Ϫ1 ⅐ g PLW Ϫ1 . Total vascular resistance (R tot ) was calculated from P A and P V pressures by using whereas pre-and postcapillary resistance (R A and R V , respectively) was calculated from
Assessment of Cl iso and alb
The principles for these measurements have been described in detail by Rippe and Haraldsson (28) , as modified for lung and to allow measurements of both Cl iso and alb by Kern et al. (18) . These entities were determined by using two separate albumin tracers, 125 I-labeled BSA (tracer I; NEN-DuPont, Boston, MA) and 131 I-labeled HSA human serum albumin (tracer II; IsoTex Diagnostics, TX), which were purified to 99.9% to rid the tracer of free label and small-molecular contaminants by using PD-10 gel filtration disposable columns (Pharmacia, Sweden). The levels of free 125 I and 131 I were determined in the perfusate at the end of the experiments by using 10% trichloroacetic acid (TCA) preparation and were below 0.8% for 125 I-labeled albumin and below 0.3% for 131 I-labeled albumin. Tracer I was used to measure the initial Cl iso during 7-8 min, whereas tracer II was used to measure the convective albumin clearance during transvascular filtration over a 7-to 8-min period after a defined increase in microvascular pressure produced by raising P A and P V by the same amount. Tracer I (4-5 Ci) was contained in a separate circuit (perfusate II) containing 70 ml of perfusate. It was possible to instantly switch to this perfusate containing tracer by using stopcocks. The perfusate reached the lung within 10 s, and the switch did not affect P A , P V , P C , weight, or P airw levels. A sampling from the tracer I reservoir (ϳ0.3 ml at a time) was made at 2-min intervals. At 6 min, we suddenly added 4-5 Ci in 0.5 ml of tracer II to the tracer I (perfusate II) reservoir and stirred vigorously. An air bubble in the arterial line, which was later trapped within a bubble trap, delineated when the new tracer replaced the first. After the air bubble entered the bubble trap, P A and P V were rapidly and simultaneously raised to induce vascular filtration. Sampling of perfusate was then again performed at 2-min intervals. After 6-8 min of tracer I ϩ tracer II perfusion, a switch was made to the unlabeled "cold" perfusate (perfusate I) to completely wash the lung's vasculature free of tracer. Washout fluid (ϳ40-50 ml) reduced tracer concentration to usually Ͻ0.2% of the initial perfusate value. In a few preliminary experiments, only tracer I was used during strictly isogravimetric conditions. After a tracer washout, the lungs were removed, the right and left lungs were blotted and weighed in tared test tubes separately, and then radioactivity was assessed for 125 I and 131 I. Appropriate corrections for spillover and radioactive decay were also performed. A minimum of 10,000 counts/min (CPM) per sample were also counted on a Wallac scintillator (model 1282, CompuGamma, Turku, Finland). Lung samples were dried at 60°C until a constant weight was obtained (ϳ72 h).
Calculations
Plasma equivalent space (S I , in ml/100 g) of tracer I, isogravimetry plus elevated microvascular pressure, was calculated as
Plasma equivalent space (S II , in ml/100 g) of tracer II, elevated pressure alone, was assessed as
Cl iso or apparent PS was calculated as
where Time I is time for perfusion with tracer I only. Time II is time for perfusion with tracer I ϩ II. Note that Cl iso contains both a diffusive term (PS) and a term due to "volume recirculation" of fluid between large and small pores during isogravimetric conditions (28) (29) (30) . It could, however, be calculated that this term was rather small (ϳ20% of Cl iso ) by using current data for small and large pore radius (60 and 250 Å, respectively) and for the fraction of L p S accounted for by the large pores (0.01-0.15) (29, 40) .
Clearance during transvascular filtration (Cl F ) was calculated as
J V is the average filtration rate occurring during Time II , defined as total weight gain minus the first minute weight gain divided by the elapsed time during pressure elevation. The use of Eq. 8 deviates from the linear equation (17) but is justified according to the nonlinear flux equation (22), because J V was usually Ͼ2 ml⅐ min Ϫ1 ⅐ 100 g Ϫ1 , PS ϳ0.2 ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 , and alb ϳ0.65, yielding a Peclet number [J V ⅐ (1Ϫ)/PS], which is Ͼ3. Under this condition the Patlak equation (22) reduces to Eq. 8, and hence, the apparent PS term approaches zero (1, 28, 40) .
The degree of edema (E) was calculated from dry-to-wet weight ratio of experimental lungs (DW/WW) E and those of controls (DW/WW) O , i.e., 0.18, from the formula
The edema factor, f E ϭ 1 ϩ E/100, was used to always standardize the extravascular albumin space to tissue dry weight (actually to the wet tissue weight before any edema formation had occurred), by multiplication of all albumin spaces by f E .
Experimental Protocol
Cooling experiments (n ϭ 7). After preparation and a period of stabilization (10-15 min) during which the lung was allowed to become completely isogravimetric, a control L p S (10-12 min) was assessed, after which the lung again reached isogravimetric conditions and P C was determined by using the double-occlusion technique. By suddenly reducing the heater temperature and that of the heated (arterial) reservoirs to ϳ8°C (from 38°C), the perfusate temperature was reduced to ϳ22°C within 3-5 min. Perfusate temperature in the reservoir was measured by using simple mercury lab thermometers. After approximately another 10 min, a double-occlusion P C was again determined, after which the tracer infusion started and Cl iso and alb were determined during 7 ϩ 7 min, according to the procedures previously described.
NEM (n ϭ 5) and filipin (n ϭ 6) groups. NEM and filipin were both obtained from Sigma Chemical. When the preparation became isogravimetric after an initial L p S determination, NEM was infused for 4 min directly proximal to the P A cannula to produce a final concentration of 0.13 mM (24, 34) . Cl iso and alb were then determined according to the descrip-tion presented in Assessment of Cl iso and alb and Calculations. In the filipin group, filipin concentrations of 0.22, 0.44, 0.9, and 0.9 g/ml (one concentration per animal, n ϭ 4) were tested without yielding any significant effects on either Cl iso , L p S, or alb (36) . Therefore, in two experiments, a filipin concentration of 1.8 g/ml was infused.
Control experiments (n ϭ 8 ϩ 5). In eight control experiments, a sham infusion of NaCl (0.3 ml/min) was given before the determinations of Cl iso and alb . In five preliminary control experiments, which are included in the main control group, only one albumin tracer ( 125 I-BSA) was employed, and therefore some determinations were not performed in the control group.
Statistics
All values are expressed as means Ϯ SE unless otherwise stated. alb and Cl iso in control groups were compared with those in test groups by using a one-way ANOVA with a post hoc Bonferroni's test. In a majority of experiments, L p S values could be determined both in control and in test situation, the latter from the fluid filtration occurring during tracer I ϩ II perfusion at 7 to 8 min. Also vascular resistances and P C values could be compared between control and test situation in each animal. In these experiments test versus control values were tested by using paired t-tests. P values Ͻ 0.05 were considered significant.
RESULTS
Effects of Cooling (n ϭ 7)
These results are summarized in Fig. 1 . Cooling the lungs from 35°to 22°C caused only slight decreases in L p S (from 0.221 Ϯ 0.014 to 0.170 Ϯ 0.022 ml ⅐ min Ϫ1 ⅐ cmH 2 O Ϫ1 ⅐ 100 g Ϫ1 ) (P Ͻ 0.05) and in Cl iso (from 0.230 Ϯ 0.019 to 0.167 Ϯ 0.0134 ml ⅐ min Ϫ1 ⅐ 100 g
Ϫ1
; P ϭ 0.07). Furthermore, there were no significant changes in alb between 35°and 22°C (0.652 Ϯ 0.049 vs. 0.661 Ϯ 0.025). There was a slight but significant increase in R tot from 0.52 Ϯ 0.018 to 0.61 Ϯ 0.018 cmH 2 O ⅐ ml Ϫ1 ⅐ min ⅐ g (P Ͻ 0.01) but only a minor change in P C (from 7.2 Ϯ 0.11 to 7.4 Ϯ 0.18 cmH 2 O).
Effects of NEM
Preliminary experiments with NEM indicated that both 0.5 mM (n ϭ 1) and 0.3 mM (n ϭ 3) used in previous studies (24, 25, 34) caused marked increases in Cl iso . For 0.3 mM NEM, Cl iso increased from 0.230 Ϯ 0.019 to 0.821 Ϯ 0.419 ml ⅐ min Ϫ1 ⅐ 100 g
Ϫ1
; n ϭ 3. Therefore, a lower dose (0.13 mM) was tested. NEM (0.13 mM) caused a significant increase in Cl iso from 0.230 Ϯ 0.019 ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 (n ϭ 13) in control experiments to 0.374 Ϯ 0.048 (n ϭ 5) ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 (P Ͻ 0.05) (Fig. 2 ) and also caused a marked reduction in alb from 0.652 Ϯ 0.049 (n ϭ 6) in control rats to 0.335 Ϯ 0.095 (n ϭ 5) (P Ͻ 0.05). Also L p S, measured within each experiment, increased from 0.201 Ϯ 0.017 (n ϭ 5) to 0.304 Ϯ 0.036 ml ⅐ min Ϫ1 ⅐ cmH 2 O Ϫ1 ⅐ 100 g Ϫ1 (n ϭ 5) (P ϭ 0.061). There was also a tendency toward an increased vascular resistance from 0.57 Ϯ 0.06 cmH 2 O ⅐ ml Ϫ1 ⅐ min ⅐ g (n ϭ 5) to 0.63 Ϯ 0.06 cmH 2 O ⅐ ml Ϫ1 ⅐ min ⅐ g (n ϭ 5) (P ϭ 0.08) during NEM infusions, whereas no statistically significant increases occurred in P C (7.28 Ϯ 0.13 in control vs. 7.88 Ϯ 0.38 cmH 2 O).
Effects of Filipin (n ϭ 6)
For low doses of filipin (Յ0.9 g/ml) (n ϭ 4), we noted no significant changes in either Cl iso , alb , or L p S. However, Cl iso seemed to increase for the highest dose of filipin (1.8 g/ml) tested as evidenced from the nonlinear least squares (exponential) regression analysis shown in Fig. 3 . If all Cl iso values in the filipin group were pooled and compared with control (Fig. 4) , a statistically significant increase in this parameter from 0.230 Ϯ 0.019 (n ϭ 13) to 0.396 Ϯ 0.089 (n ϭ 6) ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 (P Ͻ 0.05) was observed, whereas the tendency of the decreased alb from 0.652 Ϯ 0.049 to 0.423 Ϯ 0.084 was not statistically significant. Also, no significant changes occurred in vascular resistance.
DISCUSSION
The present results support the contention of passive, pore-type transfer of tracer albumin across the Fig. 1 . Effects of temperature reduction (solid bars) on isogravimetric albumin clearance (Cl iso , ml⅐ min Ϫ1 ⅐ 100 g Ϫ1 ), the capillary ultrafiltration coefficient (L p S, ml⅐ min Ϫ1 ⅐ cmH 2 O Ϫ1 ⅐ 100 g Ϫ1 ), the albumin reflection coefficient, alb (dimensionless), and total vascular resistance (R tot , cmH 2 O ⅐ ml Ϫ1 ⅐ min ⅐ g) compared with control (open bars). Moderate cooling produced only slight changes (ϳ30%) in both R tot (**P Ͻ 0.01) and L p S (*P Ͻ 0.05). Cl iso tended toward reduction, but the reduction compared with control was not statistically significant according to the corrected ANOVA. 
, and R tot (ml ⅐ min Ϫ1 ⅐ cmH 2 O ⅐ 100 g) compared with control (open bars). Statistically significant (**P Ͻ 0.05) differences occurred in both the Cl iso and L p S, which both increased. Furthermore, there was a reduction in alb (*P Ͻ 0.05). microvessels in ventilated rat lungs perfused under strictly controlled hemodynamic conditions by using a buffered PSS-albumin serum solution. Thus reducing perfusate temperature from 35°to 22°C only moderately reduced transvascular clearance of albumin during isogravimetric conditions (in due proportion to the increased viscosity) and not to the extent expected for an active transport process. Furthermore, when P C was increased, there was a clear-cut increase in albumin transport, the coupling coefficient between albumin clearance and J V being ϳ0.35, compatible with an average alb of ϳ0.65 both at 35°and 22°C. Finally, the use of transcytosis inhibitors in concentrations expected to affect vesicular transport did not reduce transvascular albumin clearance from control in our experiments. In contrast, even low doses of NEM (0.13 mM) and high doses of filipin (1.8 g/ml) actually increased Cl iso and reduced alb , at least after NEM, concomitant with increases in capillary hydraulic conductance, indicating that NEM and filipin both altered microvascular permeability.
The microvascular changes after NEM in the present experiments mimick those recently obtained in isolated perfused rat hindquarters (Carlsson O, Rosengren B-I, and Rippe B, unpublished observations) or in singly perfused frog mesenteric capillaries (Michel and Neal, personal communications), although the present doses of NEM were somewhat lower and did not markedly affect vascular resistance. However, they are in stark contrast to the apparent transport inhibition by NEM obtained by Schnitzer et al. (34) (35) (36) in in situ perfused rat lungs. The apparent PS (Cl iso ) during control in studies by Schnitzer et al. was about threeto fivefold higher than that in our experiments. The reason for this discrepancy is not known. A major difference between the experiments of Schnitzer et al. and the present study is that our perfusate always contained 10 vol% serum and that the albumin concentration was higher. Furthermore, lung cannulation, isolation, and perfusion were always preceded by heparinization of the animals in our experiments. In a preliminary study, in which only Cl iso was assessed, we found that the apparent PS increased approximately threefold when serum was absent from the perfusate. These clearance data agree with those of Sunnergren et al. (39) , who studied albumin clearances in serum free but PSS-albumin-perfused rat lungs in vitro. The serum effect is well documented for rat muscle capillaries (11, 12) , rat glomerular vessels (9), frog mesenteric capillaries (4, 14) , and partly for rat lung microvessels (35) . The way that serum, or actually orosomucoid, exerts its effects is not known, but previous studies have indicated that orosomucoid affects the charge-selective properties of the capillary walls, making them physiologically negatively charged (4, 12) . The serum effect may be one of the reasons for the observed discrepancy in control albumin clearance of the present experiments and those by Schnitzer et al. (34) (35) (36) .
Another major discrepancy between the present experiments and the in situ perfusions by Schnitzer et al. is the relatively longer tracer-loading period in the present experiments than in those by Schnitzer et al., i.e., ϳ15 min for tracer I and 7-8 min for tracer II, versus 3 min in the studies of Schnitzer et al., and the seemingly better-controlled washout in the present study. Whereas the tracer loading and the tracer washout periods were about equal in length (3 min) in Schnitzer's (34-36) experiments, the washout periods in the present experiments accounted for only 20-50% of the tracer loading periods. In the original lung tissue uptake studies by Kern et al. (18) , there were no significant reductions in Cl iso as a function of tracer perfusion time during tracer perfusion periods up to 30 min, the half-time of the (exponential) lung albumin tissue (saturation) uptake curve being 77 min. The calculated theoretical reduction in clearance by using 15 min instead of 3 min of tracer loading is actually negligible (ϳ5.5%). Therefore, the longer tracer loading periods used here are preferred because of the larger tracer albumin space monitored (more CPM/g to be counted), especially in relation to any residual tracer Figs. 1 and 2 . The change in Cl iso after filipin was statistically significant (*P Ͻ 0.05). However, the apparent reduction in alb was not statistically significant. remaining in the intravascular space. This may have reduced errors in determinations of clearance and alb in our experiments. Furthermore, and more importantly, strict precautions were taken in the present experiments to produce an efficient washout. In a majority of experiments the final rinse fluid contained only ϳ0.1% of the initial tracer concentration.
The average Cl iso in our experiments is similar to that determined in rats in vivo from albumin kinetic studies (38) but slightly higher than values obtained by using dual isotope techniques for separation of extravascular from intravascular albumin spaces in vivo. With the use of such techniques, Haraldsson et al. (10) reported lung albumin clearance in rats in vivo to be 0.116 ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 from the 30-min extravascular tracer albumin space, similar to that of Dewey (6) (0.100 ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 ).
The latter values are remarkably close to those reported by Ishibashi et al. (16) combining tissue uptake and lymphatic flux analyses in intact dog lungs (0.103 ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 ). Our Cl iso data are one-third as high as those obtained in in vitro-perfused lungs without serum in the perfusate (39) , which is most likely due to the presence of serum in our study. In one previous in vivo study rat lungs were cannulated in situ to wash out intravascular tracer albumin previously administered to the whole animal, the washout lasting for 3 min (5). In that study, however, albumin clearance was markedly higher than in the other in vivo studies mentioned above, and it is speculated that in situ vascular washout procedures, especially if the animal is not heparinized, may not have been adequate. If vascular washout had indeed been incomplete in the aforementioned in situ studies, including those of Schnitzer et al. (34) (35) (36) , the effects of NEM or filipin may be ascribed to vasoconstriction and reductions in vascular capacitance. This would affect apparent distribution volume, hence, apparent clearance, of both small and large proteins, which show a large intravascular-to-extravascular space ratio in experiments of short duration. However, for small solutes, intravascular distribution volume is rather insignificant compared with the total extravascular distribution volume in experiments lasting a few minutes, and any changes in the former would not affect solute distribution volumes or estimates of bloodto-tissue clearances significantly.
It is not completely understood how NEM and filipin affect vascular permeability. However, NEM is an alkylating agent, which acts like a fixative, causing marked crosslinking of proteins of, i.e., the cytoskeleton as well as of those of the plasmalemma. Membranedamaging effects may also be produced by high doses of filipin, because filipin is a sterol-binding agent, which removes cholesterol from the plasmalemma, thereby potentially disrupting the cell membrane. The present study and a parallel one by Carlsson O, Rosengren BI, and Rippe B (unpublished data) clearly point out the unsuitability of using NEM and filipin as transcytosis inhibitors. As it seems, the only physiological transcytosis inhibitor available at present is cooling. In the present experiments, however, cooling caused only moderate reductions in albumin clearance, which was reduced largely in proportion to the cooling-induced changes in viscosity produced.
During the past two decades, much has been learned about the general principles of vesicle shuttling between donor and target membranes in cells. The formation of a vesicle (vesicle budding) includes the formation of a protein shell from cytosolic proteins, named a "coat," which sculpts the vesicle out of the donor membrane. This vesicle budding is triggered by a GTP-dependent protein. In the next step the vesicle is detached and "decoated," allowing passage of the vesicle across the cell, usually by passive mechanisms. The vesicle and its target membrane have specific identifiers (so-called "SNAREs" or "SNAP receptors"), which can bind to each other, thereby eventually docking the vesicle to the target membrane, usually after minutes of transcellular passage. NEM-sensitive fusion protein, N-ethylmaleimide-sensitive factor (NSF), and soluble NSF attachment protein (SNAP) bind to the docking receptor complex, disrupting the complex and initiating fusion, when NSF hydrolyzes ATP. Thus at least two of the processes in vesicular shuttling, budding from the donor membrane and fusion with the target membrane, are dependent on the cellular metabolism. As such they should have a temperature coefficient of the order of 2.5-3, which would imply a reduction in shuttling velocity by ϳ70% for a temperature reduction from 35°to 22°C. However, if transport occurred by pure convection through large pores, then the reduction in transport would be exactly inversely proportional to the increase in viscosity. In that case, transport would be reduced by 25%. A diffusive process would, according to the Stokes-Einstein equation, be reduced by 28% for the same temperature reduction. These figures are more or less exactly consistent with the cooling-induced reduction found in albumin transfer in the present study, although statistically, the reduction in Cl iso at 22°C was of borderline significance (P ϭ 0.07). Our data thus strongly favor passive transport mechanisms as driving the transendothelial protein transport. Also the fact that the coupling between albumin transfer and fluid transfer, via (1Ϫ alb ), was completely unchanged during cooling, supports this contention. In addition, although NEM even in low doses altered microvascular permeability, low doses of filipin left vascular permeability relatively unperturbed. Thus low doses of filipin did not reduce transendothelial albumin transport.
The present study does not refute the presence of endocytotic and exocytotic pathways or transcytosis of proteins across the endothelium in general. However, the mere existence of a pathway does not prove that it is quantitatively important. Hastings et al. (13) proved the existence of a monensin and nocodazole-inhibitable endocytotic pathway in cultured alveolar type II cells. They furthermore showed, by using immunohistochemical techniques, that transcytosis inhibition disturbed the albumin uptake from the alveoli in vivo. However, when the quantitative alveolar clearance of 125 I-labeled immunoglobulin G or 131 was investigated in anesthetized rabbits, there was no significant inhibition of this bulk protein transport from the alveoli to the plasma. The authors concluded that endocytic pathways are insufficient to account for the clearance of large quantities of serum proteins from normal alveoli. It is then likely, that endocytotic and exocytotic mechanisms, in e.g., endothelia, have other primary functions than being a bulk transfer mechanism for proteins. This does not deny that transcytosis may be of importance in highly specific transendothelial protein transport processes of, e.g., signal peptides, such as procolipase (31) , hormones, such as insulin (14) , or even cytokines and chemokines. It is also possible that plasmalemmal vesicles may fuse to form large patent transendothelial channels (37) . However, so far we have found no evidence supporting the hypothesis that active transcytosis produces bulk transfer of plasma protein from blood to tissues.
In summary, the present study supports the contention of passive transfer of albumin across the lung's microvascular endothelium. Tissue cooling failed to produce the marked reduction in albumin clearance, which would be expected for an active transport process. Furthermore, the transcytosis inhibitors NEM and filipin did not reduce albumin clearance across lung microvessels. In fact, both NEM and filipin, used as transcytosis inhibitors in many previous studies, produced changes in microvascular exchange parameters that are compatible with increases in microvascular permeability. The data suggest that both NEM and filipin produce some form of toxic endothelial damage of the microvascular barrier in isolated perfused rat lungs.
